Table of Contents
Molecular Biology International
Volume 2012 (2012), Article ID 705948, 8 pages
http://dx.doi.org/10.1155/2012/705948
Research Article

Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy

Molecular Targets Program, Department of Medicine, James Graham Brown Cancer Center, University of Louisville, 505 S. Hancock Street, Louisville, KY 40202, USA

Received 9 February 2012; Accepted 27 March 2012

Academic Editor: Farida Latif

Copyright © 2012 Jennifer Clark et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jennifer Clark, Jessica Freeman, and Howard Donninger, “Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy,” Molecular Biology International, vol. 2012, Article ID 705948, 8 pages, 2012. doi:10.1155/2012/705948